-

CITRIX SHAREHOLDER ALERT: Robbins LLP Informs Investors that Citrix Systems, Inc. (CTXS) is Being Sued for Misleading Investors

SAN DIEGO--(BUSINESS WIRE)--Shareholder rights law firm Robbins LLP informs investors that a class action was filed on behalf of all persons and entities that purchased Citrix Systems, Inc. (NASDAQ: CTXS) securities between January 22, 2020 and October 6, 2021. The complaint alleges violations of the Securities Exchange Act of 1934. Citrix is a software company that provides users with secure remote access to computer networks.

If you suffered a loss due to Citrix Systems, Inc.'s misconduct, click here.

Citrix Systems, Inc. (CTXS) Misled Investors Regarding Subscriber Interest in its Cloud-Based Service

According to the complaint, in 2019, Citrix announced it would be shifting from a perpetual license model to a subscription license payment model, as well as transitioning from a software solution previously provided on-premises to a cloud-based service. During the class period, the Company claimed that the transition to a cloud-based product and to a subscription-pricing model was going smoothly and successfully.

Then, on April 29, 2021, Citrix announced lower than expected license conversions and that customers were not transitioning to the long-term cloud contracts as expected. On this news, the stock price fell 7.6%. However, the Company continued to assure investors that this was a "very isolated item" and that the "transition to the cloud is progressing well."

On July 29, 2021, Citrix reported that, despite prior assurances, the transition to the cloud was not as successful as the Company had led investors to believe. Citrix also announced a major restructuring of its sales leadership in order to "enhance [its] focus on" cloud migration. These changes were "significant and may cause short-term disruption before yielding tangible results." Following these disclosures, Citrix's stock dropped from $114.55 to $99.00 per share, or 13.6%.

Finally, on October 6, 2021, Citrix announced that its president and chief executive officer had stepped down. On this news, the Company's stock dropped from $105.96 to $98.32 per share over the next two days.

If you purchased shares of Citrix Systems, Inc. (CTXS) securities between January 22, 2020 and October 6, 2021, you have until January 18, 2022, to ask the court to appoint you lead plaintiff for the class.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.

Contact us to learn more:

Aaron Dumas
(800) 350-6003
adumas@robbinsllp.com
Shareholder Information Form

About Robbins LLP: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002. To be notified if a class action against Citrix Systems, Inc. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch today.

Attorney Advertising. Past results do not guarantee a similar outcome.

Contacts

Aaron Dumas
Robbins LLP
5040 Shoreham Place
San Diego, CA 92122
adumas@robbinsllp.com
(800) 350-6003
www.robbinsllp.com

More News From Robbins LLP

Investor Notice: Robbins LLP Informs Investors of the FS KKR Capital Corp. Class Action

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired FS KKR Capital (NYSE: FSK) securities between May 8, 2024 and February 25, 2026. FS KKR Capital is a private credit firm, also known as Business Development Company, which specializes in making private loans to companies.For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.The Allegations: Ro...

Robbins LLP Urges GOSS Stockholders to Contact the Firm for Information About the Class Action Against Gossamer Bio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Gossamer Bio, Inc. (NASDAQ: GOSS) securities between June 16, 2025 and February 20, 2026. Gossamer is a clinical stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary hypertension (PH) associated with interstitial lung disease.For more information, submit a form, email att...

Robbins LLP Urges IBRX Stockholders to Contact the Firm for Information About the Class Action Against ImmunityBio, Inc.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired ImmunityBio, Inc. (NASDAQ: IBRX) securities between January 19, 2026 and March 25, 2026. ImmunityBio is a biotechnology company and ANKTIVA is the Company's lead biologic product. For more information, submit a form, email attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003. What is the class period? January 19, 2026 – March 25, 202...
Back to Newsroom